HMI Radiology (Novena) will deliver a full suite of diagnostic imaging services to aid in early detection and proactive health management in the community Integration of Siemens Healthineers ...

You will be redirected to our submission process. Accurate detection and characterization of the electrophysiological substrate underlying atrial tachycardia (AT) represent a critical frontier in ...

Patients with an aggressive form of breast cancer who are not candidates for immune checkpoint inhibitor therapy showed significantly improved progression-free survival when treated with the antibody ...

GSK plc (NYSE:GSK) and Syndivia on Monday announced an agreement granting GSK exclusive worldwide rights to develop and commercialize a preclinical ADC for metastatic castration-resistant prostate ...

The Model 270+ is a powerful two-channel diagnostic audiometer, featuring advanced technology for a more precise and effective testing experience. For audiologists, ENTs, and hearing aid providers, it ...

In the phase III OptiTROP-Lung04 study, the antibody–drug conjugate sacituzumab tirumotecan (sac-TMT) led to dramatic improvements in progression-free and overall survival compared with chemotherapy ...

Patients with an aggressive form of breast cancer who are not candidates for immune checkpoint inhibitor therapy showed significantly improved progression-free survival when treated with the antibody ...

BERLIN October 19, 2025 – Patients with an aggressive form of breast cancer who are not candidates for immune checkpoint inhibitor therapy showed significantly improved progression-free survival when ...

SUZHOU, China, Oct. 20, 2025 /PRNewswire/ — October 20, 2025- Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that ...